Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue

Summary

Here, we present two novel methodologies, psPACT and mPACT, for achieving maximal optical transparency and subsequent microscopic analysis of tissue vasculature in the intact rodent whole CNS.

Abstract

Since the development of CLARITY, a bioelectrochemical clearing technique that allows for three-dimensional phenotype mapping within transparent tissues, a multitude of novel clearing methodologies including CUBIC (clear, unobstructed brain imaging cocktails and computational analysis), SWITCH (system-wide control of interaction time and kinetics of chemicals), MAP (magnified analysis of the proteome), and PACT (passive clarity technique), have been established to further expand the existing toolkit for the microscopic analysis of biological tissues. The present study aims to improve upon and optimize the original PACT procedure for an array of intact rodent tissues, including the whole central nervous system (CNS), kidneys, spleen, and whole mouse embryos. Termed psPACT (process-separate PACT) and mPACT (modified PACT), these novel techniques provide highly efficacious means of mapping cell circuitry and visualizing subcellular structures in intact normal and pathological tissues. In the following protocol, we provide a detailed, step-by-step outline on how to achieve maximal tissue clearance with minimal invasion of their structural integrity via psPACT and mPACT.

Introduction

A fundamental objective of scientific and clinical inquiry involves attaining a complete understanding of organ structure and function; however, the exceedingly complex nature of mammalian organs often serves as a barrier to fully achieving this aim¹. CLARITY (Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging-compatible Tisssue-hYdrogel)^2,3,4, which involves building an acrylamide-based hydrogel hybrid from intact tissues, achieves optical clearance of a variety of organs, including the brain, liver, and spleen, while preserving their structural integrity⁵. CLARITY has thus enabled not only visualization but also the opportunity to finely dissect complex cellular networks and tissue morphologies without the need for sectioning.

In order to achieve tissue clearance, CLARITY employs electrophoretic methods to remove the lipid content of the sample at hand. While CLARITY has been noted for producing physically stable tissue-hydrogel hybrids, studies have shown that its use of electrophoretic tissue clearing (ETC) methods yields variable results in terms of tissue quality, including browning, epitope damage, and protein loss^5,6. To address these issues, modified protocols such as PACT (PAssive Clarity Technique), which replaces the ETC treatment with a passive, ionic-detergent based delipidation technique, have been developed^7,8,9. Despite achieving a greater consistency in results, however, PACT requires more time to obtain maximal clearance. Furthermore, none of these techniques have yet been applied to the whole CNS form, or in larger rodent models such as rats and guinea pigs.

The present study seeks to address these limitations by proposing novel methodologies, psPACT (process-separate PACT) and mPACT (modified PACT), for facilitating the fast clearance of the whole CNS and internal organs in both mouse and rat models¹⁰. Specifically, psPACT processes tissues in 4% acrylamide and 0.25% VA-044 in two separate steps during hydrogel formation; mPACT essentially involves the same steps, but supplements the SDS-based clearing solution with 0.5% α-thioglycerol as a key reagent. Both techniques harness the endogenous systemic and cerebrospinal circulatory systems to significantly reduce the time needed to produce optical clearance. As a proof of principle, we demonstrate the use of confocal microscopy to analyze blood vessel patterns in the cleared tissues¹⁰.

Protocol

All procedures have been approved by the appropriate research ethics committee at Yonsei University College of Medicine. All experimental animals are sacrificed in accordance with the guidelines of the laboratory animal care committee at Yonsei University College of Medicine.

1. Preparation of Reagents

Caution: Paraformaldehyde (PFA), acrylamide and sodium dodecyl sulfate (SDS) are toxic irritants and thus should be handled in a fume hood with appropriate personal protective equipment (PPE; lab coat, gloves, protective eyewear).

1. 4% acrylamide (A.A) solution (A4P0): Add 20 mL of 40% acrylamide solution to 180 mL of 0.1 M phosphate-buffered saline (PBS).
2. 0.25% VA-044 solution: Add 0.5 g of 2,2´-Azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride (VA-044) powder to 200 mL of 0.1 M phosphate-buffered saline (PBS). While the VA-044 powder can be stored at room temperature, it must be stored at 4 °C upon solubilization in PBS. For best results, prepare only the amount of solution needed for the experiment.
3. PACT cocktail solution: Add 10 g of acrylamide to 225 mL of 4% paraformaldehyde (PFA) solution and adjust the volume to 200 mL with 4% PFA. Prior to use, add 100 mg of VA-044 powder to 40 mL of mixture in a 50 mL conical tube.
4. PACT clearing solution buffer: Add 40 g of sodium dodecyl sulfate (SDS) to 350 mL of 0.1 M PBS and adjust the volume to 500 mL with 0.1 M PBS. For mPACT clearing solution, add 0.5% α-thioglycerol to the PACT clearing solution buffer.
5. The mice used in this study were 2-week-old BALB male mice; the rats used in this study were 2 week old male SD-rats.

2. Anesthesia and Perfusion Surgery

Caution: PFA and acrylamide are toxic irritants and thus should be handled in a fume hood with appropriate PPE.

1. Anesthetize the animal in a pathogen-free room with 30 mg/kg of zoletil using a 1 mL syringe with a 26-gauge needle. Monitor the animal for 5 -10 min.
2. Once the animal has reached a surgical plane of anesthesia, use the toe-pinch response method to determine the depth of anesthesia. Confirm unresponsiveness.
   NOTE: The following steps involving mouse and rat surgery follow a similar protocol used in a previous study¹¹.
3. Make a 5-6 cm incision beneath the rib cage, through the integument and abdominal wall.
4. Use curved, blunt scissors to make an incision in the diaphragm, palpating the thoracic area to locate the site of incision beforehand.
5. Extend the incision across the entire length of the ribcage to expose the pleural cavity.
6. Carefully displace the lungs. Make a cut through the ribcage up to the collarbone. Using iris scissors, make a small incision to the posterior end of the left ventricle. Insert an 18-gauge blunt- or olive-tipped perfusion needle into the ascending aorta, passing through the cut ventricle.
7. Secure the needle and prevent leakage by clamping the heart with a hemostat. Alternatively, use a modified hemostat to clamp the aorta around the needle tip.
8. Make a large incision in the right atrium, taking care to ensure minimal damage to the descending aorta. The rat is now ready for perfusion.

3. Whole Perfusion and Dissection of Rat

Caution: PFA and acrylamide are toxic irritants and thus should be handled in a fume hood with appropriate PPE.

NOTE: The following whole perfusion steps are a similar to a protocol used in a previous study by Woo et al. (2016)^10,11.

1. Attach the right atrium of heart to an 18-gauge needle, taking care to not introduce any air bubbles.
2. Using a 50 mL syringe, quickly and evenly pump 50 mL of cold 0.1 M PBS solution containing heparin (10 units/mL).
3. Connect the 18-gauge needle to the tube of the peristaltic pump.
4. Wash with 200 mL of cold 0.1 M PBS solution containing heparin (10 units/mL) at a circulation velocity of 10 mL/min.
5. Fix with 250 mL of cold 4% PFA solution at a circulation velocity of 10 mL/min. The rat should be stiff at this stage.
6. Collect and store the remaining PFA solution for disposal.
7. For PACT, perfuse tissues with a chilled PACT cocktail solution of 4% PFA, 4% acrylamide, and 0.25% VA-044 powder with an 18-gauge needle, and then remove the head and spine. Expose the skull by making a midline incision from the neck to the nose. This additional perfusion step is unnecessary for the psPACT and mPACT methods; after fixation, immediately isolate the head and spine and expose the skull.
8. Expose the base of the skull by removing any residual neck and spine muscle.
9. Use rongeurs and scissors to peel away the skull. Remove the brain and spinal cord.
10. Store the tissue in 4% PFA at 4 °C; tissues can be stored for up to 1 week.

4. Hydrogel Monomer Infusion and Polymerization of the Rat and Mouse CNS

Caution: Acrylamide, SDS, α-thioglycerol and PFA are irritants and thus should be handled in a fume hood and with appropriate PEE.

1. PACT (Passive Clearing Technique)
   1. Isolate and culture the whole CNS (brain and spinal cord) from fixed mice and rats to a 50 mL tube containing a chilled PACT cocktail solution of 4% PFA, 4% acrylamide, and 0.25% VA-044 powder and store at 4 °C for 24 h. Ensure that the tissue is completely immersed in the solution.
   2. Embed the sample in nitrogen gas for 10 min using a tissue gel hybridization system connected to a nitrogen tank: Set the system to 37 °C. Transfer tissues to a 50 mL tube containing fresh cold (4 °C) PACT cocktail solution and connect with tube cap, then turn on the vacuum.
   3. To polymerize the hydrogel, place the tube containing the sample in a shaking incubator (150 rpm, 37 °C) for 3 h, or until polymerization is complete.
   4. Using blotting paper (see Table of Materials), remove the remaining polymerized hydrogel surrounding the tissues.
   5. Transfer the tissue to a 50 mL tube containing clearing solution (8% SDS in 0.1 M PBS, pH 8.0).
   6. Place the sample in a shaking incubator set to 37 °C and 150 rpm until the tissue has been cleared. On average, it takes about 20 days for the mouse CNS to achieve full clarity.
2. psPACT (process separate Passive Clearing Technique)
   1. Isolate the whole CNS (brain and spinal cord) with bone cutter and scissors from PFA-fixed mice and rats on a clean bench.
   2. Transfer tissues to a 50 mL tube containing 4% PFA, and store at 4 °C for 24 h. Ensure that the tissue is completely immersed in the fixative.
   3. Wash the fixed tissue for 1 h in 0.1 M PBS, and then transfer to A4P0 solution (4% acrylamide in 0.1 M PBS). Store at 37 °C for 24 h.
   4. Wash the tissue for 5 min in 0.1 M PBS.
   5. Immerse the tissue in 0.25% VA-044 in 0.1 M PBS. Store at 37 °C for 6-24 h, and then transfer to fresh 0.25% VA-044/PBS solution.
   6. Embed the sample in nitrogen gas for 10 min using a tissue gel hybridization system (see Table of Materials) connected to a nitrogen tank: Transfer tissues to a 50 mL tube containing fresh cold (4 °C) 0.25% VA-044/PBS solution, and connect with tube cap. Turn on the vacuum.
   7. Transfer the tissue to clearing solution (8% SDS in 0.1 M PBS, pH 8.0).
   8. Incubate the sample in a shaking incubator set to 37 °C and 150 rpm until the tissue has been cleared. On average, it takes approximately 17 days for mouse CNS to achieve full clarity.
3. mPACT (modified Passive Clearing Technique)
   1. Isolate the whole CNS (brain and spinal cord) with bone cutter and scissors from PFA-fixed mice and rats on a clean bench.
   2. Follow steps 4.2.2 - 4.2.8 of the psPACT protocol.
   3. Transfer the tissue to clearing solution. Note that unlike the PACT and psPACT protocols, mPACT requires a clearing solution consisting of 0.5% α-thioglycerol in addition to 8% SDS in 0.1 M PBS, pH 8.0. α-thioglycerol is an un-browning agent that helps clear tissue more rapidly and effectively. Ensure that the tissue is fully immersed in the solution.
   4. Place the sample in a shaking incubator set to 37 °C and 150 rpm until the tissue has been cleared. On average, it takes approximately 2 weeks for mouse CNS to achieve full clarity.

5. Refractive Index Matching and Immunostaining of Cleared CNS

NOTE: nRIMS (Nycodenz-based Refractive Index Matching Solution) consists of 0.8 g/mL Nycodenz powder dissolved in 30 mL base buffer (0.01% sodium azide and Tween-20 in 0.1 M PBS, pH 8.0). It is recommended that the solution is placed in a 37 °C shaking incubator to allow for proper solvation of the powder.

1. Incubate tissues in 0.1% Triton X-100 in 0.1 M PBS for 2 h, then block with 2% bovine serum albumin (BSA) in 0.1 M PBS for 6 h.
2. Wash sections three times in PBST (0.1% Tween-20 in 0.1 M PBS) for 2 h. Stain sections with primary antibodies (in this case, an anti-rabbit PECAM-CD31 antibody, which stains blood vessels) for 2 days.
3. Stain sections with secondary antibodies (in this case, a goat anti-rabbit IgG Cy3 fluorescent conjugate) in 2% BSA for 2 days.
4. Wash labeled tissues three times in PBST for 2 h, and store in 15 mL nRIMS for 2 - 10 days.
5. Before imaging, move labeled tissues to a small amount of nRIMS on 35- or 60-mm tissue culture dishes. Fix with silicone around the bottom edge of the dish.
6. Add 1.5 - 2 mL of fresh nRIMS.

6. Image processing

1. Acquire images of cleared tissues with tile scanning using a confocal laser-scanning microscopewith 10x magnification (see Table of Materials). For of Cy3-labeled tissue, use wavelengths of 550-600 nm.

Results

Generation of a transparent model of the whole CNS using optimized passive clearing techniques

Optical clearance of mouse and rat whole CNS tissues was rapidly achieved using various passive clearing techniques (Figure 1). A schematic of tissue clearing over time is shown in Figure 2A. Unlike the original PACT method, psPACT (process-separate PACT) invo...

Discussion

While the passive, non-electrophoretic extraction methods employed in PACT significantly improved the consistency achieved with previous tissue clearing methods such as CLARITY^2,3,4,7,8, the technique still bears several shortcomings, the most pressing of which is the length of time required to achieve maximal tissue clarity¹². In the c...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Sodium Dodecyl Sulfate (SDS)	Affymetrix, Inc.	75819	Clearing solution
Nycodenz	Axia-Shield	1002424	nRIMS solution
40% Acrylamide Solution	Bio Rad Laboratories, Inc.	161-0140	Polymerization (A4P0)
2,2´-Azobis[2-(2-imidazolin-2-yl)propane] Dihydrochloride	Wako Pure Chemical Industries, Ltd.	017-19362	Polymerization (VA-044)
1-Thioglycerol	Sigma-Aldrich	M1753-100ML	Clearing solution (mPACT)
Tween-20	Georgiachem	9005-64-5	nRIMS solution
Triton X-100	Sigma-Aldrich	T8787-50ML	Immuno Staining
Bovine serum albumin (BSA)	Bovogen	BSA100	Immuno Staining
Heparin	Merck Millipore	375095	Perfusion (PBS)
Sodium azide	Sigma-Aldrich	S2002-25G	nRIMS solution
PECAM-CD31 antibody	Santa Cruz Biotechnology Inc.	sc-28188	Immuno Staining
Goat anti-rabbit-IgG Cy3 fluorescent conjugate	Jackson ImmunoResearch Inc.	111-165-003	Immuno Staining
4% Paraformaldehyde	Tech & Innovation	BPP-9004	Perfusion, Polymerization
20X Phosphate Buffered Saline (pH 7.4)	Tech & Innovation	BPB-9121	Perfusion, Buffer
10 mL stripette	Coatar	4488	Solution transfer
50 mL tube	Falcon	352070	Clearing tube
35 mm Cell culture dish	SPL	20035	Imaging
Confocal dish	SPL	211350	Imaging
1 mL syringe	Korea vaccine Co., Ltd	26G 1/2	Anesthetize
50 mL syringe	Korea vaccine Co., Ltd	21G1 1/4	Perfusion
Acrylamide	Sigma-Aldrich	A3553	Polymerization (A4P0)
Whatman 3MM paper	Sigma-Aldrich	Z270849	Blotting paper for gel removal
Confocal microscope	Zeiss	LSM780	Imaging
ZEN lite Software	Zeiss	ZEN 2012	Imaging
Peristaltic pump	Longerpump	BT100-1F	Perfusion
EasyGel	Lifecanvas Technologies	EasyGel	Tissue gel hybridization system